Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Registry following children with pulmonary hypertension over time

Collects information over time from children with pulmonary hypertension to study their disease.

Plain-language title generated from the registry record
Registry title: Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

Key facts

Where
Edmonton, CanadaSee the site

Where in Canada

  • University of Alberta EdmontonEdmonton, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
New York Medical College
Trial code
NCT02249923
Record updated
13 March 2025
Original description
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.Read full original descriptionShow less

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.

Inclusion: The subject's age of onset of pulmonary hypertension must be prior to age 18 years; The person providing consent must be able to read either Spanish or English; The subject (and/or parent/legal guardian) must be able to provide informed consent.

Exclusion: Diagnosed with pulmonary hypertension after age 18; Refusal to sign informed consent.

ClinicalTrials.gov NCT02249923